This was a multinational, prospective, non-interventional study that aimed at collecting standardized real-world data on bleeding episodes, hemophilia medication use, and health-related quality of life (QoL) from a global, heterogeneous population of participants with severe hemophilia A on currently available FVIII prophylaxis. Here, F8 is linked to hemophilia.